Nuveen, LLC Nkarta, Inc. Transaction History
Nuveen, LLC
- $363 Billion
- Q3 2025
A detailed history of Nuveen, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 95,563 shares of NKTX stock, worth $178,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,563
Previous 130,739
26.91%
Holding current value
$178,702
Previous $217,000
9.22%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NKTX
# of Institutions
129Shares Held
58.1MCall Options Held
2MPut Options Held
58.3K-
Ra Capital Management, L.P. Boston, MA10.8MShares$20.2 Million0.38% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$13.2 Million0.66% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$7.59 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$7.05 Million2.96% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.67 Million0.46% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $91M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...